Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 12 March, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo
Stock Ticker - BSE: 537536 | NSE: DENISCHEM

Denis Chem Lab Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 11, 2025, 11:26 pm

Market Cap 144 Cr.
Current Price 104
High / Low 233/101
Stock P/E14.3
Book Value 59.4
Dividend Yield2.41 %
ROCE20.1 %
ROE14.6 %
Face Value 10.0
PEG Ratio0.41

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Denis Chem Lab Ltd

Competitors of Denis Chem Lab Ltd

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Gujarat Metallic Coal & Coke Ltd 5.94 Cr. 30.0 / 77.60.00 %0.37 %2.00 % 100
Gensol Engineering Ltd 1,107 Cr. 291 1,126/29012.8 1550.00 %14.3 %20.1 % 10.0
Gagan Polycot India Ltd 0.86 Cr. 0.86/ 4.080.00 %81.2 %81.2 % 10.0
Fusion Micro Finance Ltd 1,516 Cr. 150 544/140 2510.00 %14.1 %19.6 % 10.0
Five X Tradecom Ltd 0.99 Cr. 0.48/ 9.350.00 %0.00 %0.00 % 10.0
Industry Average5,442.36 Cr202.43227.27107.920.30%21.47%71.79%9.42

All Competitor Stocks of Denis Chem Lab Ltd

Quarterly Result

MetricDec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Sales 33.8637.7739.2944.5137.3339.7342.4845.4340.0639.8541.2647.8242.84
Expenses 30.4935.6134.9938.7433.3834.9937.4540.2934.0734.7736.9141.9439.01
Operating Profit 3.372.164.305.773.954.745.035.145.995.084.355.883.83
OPM % 9.95%5.72%10.94%12.96%10.58%11.93%11.84%11.31%14.95%12.75%10.54%12.30%8.94%
Other Income 0.040.930.080.110.070.340.010.520.260.590.320.580.30
Interest 0.210.110.170.080.120.260.090.090.130.230.120.090.07
Depreciation 1.481.471.361.371.373.721.591.761.841.751.631.661.84
Profit before tax 1.721.512.854.432.531.103.363.814.283.692.924.712.22
Tax % 30.23%37.09%24.91%29.80%28.06%29.09%20.24%33.07%25.23%26.02%28.77%25.05%20.72%
Net Profit 1.200.942.153.111.830.782.682.543.202.732.083.531.76
EPS in Rs 0.860.681.552.241.320.561.931.832.311.971.502.541.27

Last Updated: February 28, 2025, 12:10 pm

Below is a detailed analysis of the quarterly data for Denis Chem Lab Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

  • For Sales, as of Dec 2024, the value is ₹42.84 Cr.. The value appears to be declining and may need further review. It has decreased from 47.82 Cr. (Sep 2024) to ₹42.84 Cr., marking a decrease of 4.98 Cr..
  • For Expenses, as of Dec 2024, the value is ₹39.01 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 41.94 Cr. (Sep 2024) to ₹39.01 Cr., marking a decrease of 2.93 Cr..
  • For Operating Profit, as of Dec 2024, the value is ₹3.83 Cr.. The value appears to be declining and may need further review. It has decreased from 5.88 Cr. (Sep 2024) to ₹3.83 Cr., marking a decrease of 2.05 Cr..
  • For OPM %, as of Dec 2024, the value is 8.94%. The value appears to be declining and may need further review. It has decreased from 12.30% (Sep 2024) to 8.94%, marking a decrease of 3.36%.
  • For Other Income, as of Dec 2024, the value is ₹0.30 Cr.. The value appears to be declining and may need further review. It has decreased from 0.58 Cr. (Sep 2024) to ₹0.30 Cr., marking a decrease of 0.28 Cr..
  • For Interest, as of Dec 2024, the value is ₹0.07 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.09 Cr. (Sep 2024) to ₹0.07 Cr., marking a decrease of 0.02 Cr..
  • For Depreciation, as of Dec 2024, the value is ₹1.84 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.66 Cr. (Sep 2024) to ₹1.84 Cr., marking an increase of ₹0.18 Cr..
  • For Profit before tax, as of Dec 2024, the value is ₹2.22 Cr.. The value appears to be declining and may need further review. It has decreased from 4.71 Cr. (Sep 2024) to ₹2.22 Cr., marking a decrease of 2.49 Cr..
  • For Tax %, as of Dec 2024, the value is 20.72%. The value appears to be improving (decreasing) as expected. It has decreased from 25.05% (Sep 2024) to 20.72%, marking a decrease of 4.33%.
  • For Net Profit, as of Dec 2024, the value is ₹1.76 Cr.. The value appears to be declining and may need further review. It has decreased from 3.53 Cr. (Sep 2024) to ₹1.76 Cr., marking a decrease of 1.77 Cr..
  • For EPS in Rs, as of Dec 2024, the value is 1.27. The value appears to be declining and may need further review. It has decreased from ₹2.54 (Sep 2024) to 1.27, marking a decrease of ₹1.27.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 7, 2025, 4:40 pm

MetricMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales 55677598112107123135109136161167172
Expenses 49606689989511012099122142146153
Operating Profit 6698141214151014192119
OPM % 11%9%12%9%12%11%11%11%9%11%12%13%11%
Other Income 0000112001112
Interest 2357653321111
Depreciation 1146766766877
Profit before tax 320-3226639111514
Tax % 34%41%78%30%37%-5%-7%26%27%30%28%26%
Net Profit 210-412642681110
EPS in Rs 3.111.170.07-4.160.891.544.583.031.634.515.668.047.28
Dividend Payout % 18%0%0%0%0%0%22%0%46%33%35%31%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2013-20142014-20152016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)-50.00%-100.00%125.00%100.00%200.00%-33.33%-50.00%200.00%33.33%37.50%
Change in YoY Net Profit Growth (%)0.00%-50.00%225.00%-25.00%100.00%-233.33%-16.67%250.00%-166.67%4.17%

Denis Chem Lab Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:10%
5 Years:6%
3 Years:15%
TTM:2%
Compounded Profit Growth
10 Years:24%
5 Years:15%
3 Years:70%
TTM:10%
Stock Price CAGR
10 Years:12%
5 Years:36%
3 Years:13%
1 Year:-24%
Return on Equity
10 Years:8%
5 Years:10%
3 Years:12%
Last Year:15%

Last Updated: Unknown

Balance Sheet

Last Updated: December 14, 2024, 1:52 pm

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital 2399121414141414141414
Reserves 7687183643454853586669
Borrowings 173148443725231493214
Other Liabilities 10121724272626252227252831
Total Liabilities 355281859410110697929699109118
Fixed Assets 1094240444050464142353836
CWIP 09010150000200
Investments 0000000000000
Other Assets 25343935495655525155627281
Total Assets 355281859410110697929699109118

Below is a detailed analysis of the balance sheet data for Denis Chem Lab Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2024, the value is ₹14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹14.00 Cr..
  • For Reserves, as of Sep 2024, the value is ₹69.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹66.00 Cr. (Mar 2024) to ₹69.00 Cr., marking an increase of 3.00 Cr..
  • For Borrowings, as of Sep 2024, the value is ₹4.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from ₹1.00 Cr. (Mar 2024) to ₹4.00 Cr., marking an increase of 3.00 Cr..
  • For Other Liabilities, as of Sep 2024, the value is ₹31.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹28.00 Cr. (Mar 2024) to ₹31.00 Cr., marking an increase of 3.00 Cr..
  • For Total Liabilities, as of Sep 2024, the value is ₹118.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹109.00 Cr. (Mar 2024) to ₹118.00 Cr., marking an increase of 9.00 Cr..
  • For Fixed Assets, as of Sep 2024, the value is ₹36.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹38.00 Cr. (Mar 2024) to ₹36.00 Cr., marking a decrease of 2.00 Cr..
  • For CWIP, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹0.00 Cr..
  • For Investments, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹0.00 Cr..
  • For Other Assets, as of Sep 2024, the value is ₹81.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹72.00 Cr. (Mar 2024) to ₹81.00 Cr., marking an increase of 9.00 Cr..
  • For Total Assets, as of Sep 2024, the value is ₹118.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹109.00 Cr. (Mar 2024) to ₹118.00 Cr., marking an increase of 9.00 Cr..

Notably, the Reserves (₹69.00 Cr.) exceed the Borrowings (4.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

No data available for this post.

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow-11.00-25.00-39.00-36.00-23.00-13.00-9.001.001.0011.0017.0020.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days111911238510410510694110857169
Inventory Days403740393552505160503943
Days Payable605381119136150102108103997990
Cash Conversion Cycle907581438553767363122
Working Capital Days671006143947595581544439
ROCE %22%16%11%5%12%9%11%11%6%14%16%20%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Promoters38.98%38.98%38.98%38.98%38.98%38.98%38.98%38.98%38.98%38.98%38.98%38.98%
Public61.02%61.02%61.02%61.02%61.03%61.03%61.02%61.02%61.01%61.02%61.01%61.01%
No. of Shareholders3,2283,2953,3623,4323,4933,7234,6354,7944,8346,0216,8577,385

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 8.045.664.511.633.03
Diluted EPS (Rs.) 8.045.664.511.633.03
Cash EPS (Rs.) 13.0411.308.665.927.84
Book Value[Excl.RevalReserv]/Share (Rs.) 57.9152.0847.8944.3242.58
Book Value[Incl.RevalReserv]/Share (Rs.) 57.9152.0847.8944.3242.58
Dividend / Share (Rs.) 2.502.001.500.750.00
Revenue From Operations / Share (Rs.) 120.94115.9198.4178.7898.11
PBDIT / Share (Rs.) 16.3013.9611.107.6411.01
PBIT / Share (Rs.) 11.308.336.953.346.21
PBT / Share (Rs.) 10.907.876.402.224.13
Net Profit / Share (Rs.) 8.045.664.511.633.04
PBDIT Margin (%) 13.4712.0411.279.6911.22
PBIT Margin (%) 9.347.187.054.246.33
PBT Margin (%) 9.016.786.502.824.20
Net Profit Margin (%) 6.644.884.582.073.09
Return on Networth / Equity (%) 13.8810.879.423.687.13
Return on Capital Employeed (%) 19.0815.3313.566.8113.66
Return On Assets (%) 10.207.906.492.454.32
Long Term Debt / Equity (X) 0.010.010.030.070.03
Total Debt / Equity (X) 0.010.020.040.140.17
Asset Turnover Ratio (%) 1.611.641.451.151.34
Current Ratio (X) 2.552.462.112.011.46
Quick Ratio (X) 2.182.081.721.631.21
Inventory Turnover Ratio (X) 8.287.877.196.337.42
Dividend Payout Ratio (NP) (%) 24.8726.4816.610.0032.92
Dividend Payout Ratio (CP) (%) 15.3313.278.650.0012.75
Earning Retention Ratio (%) 75.1373.5283.390.0067.08
Cash Earning Retention Ratio (%) 84.6786.7391.350.0087.25
Interest Coverage Ratio (X) 41.6430.2120.366.825.28
Interest Coverage Ratio (Post Tax) (X) 21.5413.269.282.462.46
Enterprise Value (Cr.) 185.7073.5188.5756.4348.49
EV / Net Operating Revenue (X) 1.110.450.640.510.35
EV / EBITDA (X) 8.213.795.755.323.17
MarketCap / Net Operating Revenue (X) 1.250.550.690.470.30
Retention Ratios (%) 75.1273.5183.380.0067.07
Price / BV (X) 2.601.221.420.840.69
Price / Net Operating Revenue (X) 1.250.550.690.470.30
EarningsYield 0.050.080.060.040.10

After reviewing the key financial ratios for Denis Chem Lab Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is 8.04. This value is within the healthy range. It has increased from 5.66 (Mar 23) to 8.04, marking an increase of 2.38.
  • For Diluted EPS (Rs.), as of Mar 24, the value is 8.04. This value is within the healthy range. It has increased from 5.66 (Mar 23) to 8.04, marking an increase of 2.38.
  • For Cash EPS (Rs.), as of Mar 24, the value is 13.04. This value is within the healthy range. It has increased from 11.30 (Mar 23) to 13.04, marking an increase of 1.74.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 57.91. It has increased from 52.08 (Mar 23) to 57.91, marking an increase of 5.83.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 57.91. It has increased from 52.08 (Mar 23) to 57.91, marking an increase of 5.83.
  • For Dividend / Share (Rs.), as of Mar 24, the value is 2.50. This value is within the healthy range. It has increased from 2.00 (Mar 23) to 2.50, marking an increase of 0.50.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 120.94. It has increased from 115.91 (Mar 23) to 120.94, marking an increase of 5.03.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is 16.30. This value is within the healthy range. It has increased from 13.96 (Mar 23) to 16.30, marking an increase of 2.34.
  • For PBIT / Share (Rs.), as of Mar 24, the value is 11.30. This value is within the healthy range. It has increased from 8.33 (Mar 23) to 11.30, marking an increase of 2.97.
  • For PBT / Share (Rs.), as of Mar 24, the value is 10.90. This value is within the healthy range. It has increased from 7.87 (Mar 23) to 10.90, marking an increase of 3.03.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is 8.04. This value is within the healthy range. It has increased from 5.66 (Mar 23) to 8.04, marking an increase of 2.38.
  • For PBDIT Margin (%), as of Mar 24, the value is 13.47. This value is within the healthy range. It has increased from 12.04 (Mar 23) to 13.47, marking an increase of 1.43.
  • For PBIT Margin (%), as of Mar 24, the value is 9.34. This value is below the healthy minimum of 10. It has increased from 7.18 (Mar 23) to 9.34, marking an increase of 2.16.
  • For PBT Margin (%), as of Mar 24, the value is 9.01. This value is below the healthy minimum of 10. It has increased from 6.78 (Mar 23) to 9.01, marking an increase of 2.23.
  • For Net Profit Margin (%), as of Mar 24, the value is 6.64. This value is within the healthy range. It has increased from 4.88 (Mar 23) to 6.64, marking an increase of 1.76.
  • For Return on Networth / Equity (%), as of Mar 24, the value is 13.88. This value is below the healthy minimum of 15. It has increased from 10.87 (Mar 23) to 13.88, marking an increase of 3.01.
  • For Return on Capital Employeed (%), as of Mar 24, the value is 19.08. This value is within the healthy range. It has increased from 15.33 (Mar 23) to 19.08, marking an increase of 3.75.
  • For Return On Assets (%), as of Mar 24, the value is 10.20. This value is within the healthy range. It has increased from 7.90 (Mar 23) to 10.20, marking an increase of 2.30.
  • For Long Term Debt / Equity (X), as of Mar 24, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.01.
  • For Total Debt / Equity (X), as of Mar 24, the value is 0.01. This value is within the healthy range. It has decreased from 0.02 (Mar 23) to 0.01, marking a decrease of 0.01.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 1.61. It has decreased from 1.64 (Mar 23) to 1.61, marking a decrease of 0.03.
  • For Current Ratio (X), as of Mar 24, the value is 2.55. This value is within the healthy range. It has increased from 2.46 (Mar 23) to 2.55, marking an increase of 0.09.
  • For Quick Ratio (X), as of Mar 24, the value is 2.18. This value exceeds the healthy maximum of 2. It has increased from 2.08 (Mar 23) to 2.18, marking an increase of 0.10.
  • For Inventory Turnover Ratio (X), as of Mar 24, the value is 8.28. This value exceeds the healthy maximum of 8. It has increased from 7.87 (Mar 23) to 8.28, marking an increase of 0.41.
  • For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 24.87. This value is within the healthy range. It has decreased from 26.48 (Mar 23) to 24.87, marking a decrease of 1.61.
  • For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 15.33. This value is below the healthy minimum of 20. It has increased from 13.27 (Mar 23) to 15.33, marking an increase of 2.06.
  • For Earning Retention Ratio (%), as of Mar 24, the value is 75.13. This value exceeds the healthy maximum of 70. It has increased from 73.52 (Mar 23) to 75.13, marking an increase of 1.61.
  • For Cash Earning Retention Ratio (%), as of Mar 24, the value is 84.67. This value exceeds the healthy maximum of 70. It has decreased from 86.73 (Mar 23) to 84.67, marking a decrease of 2.06.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is 41.64. This value is within the healthy range. It has increased from 30.21 (Mar 23) to 41.64, marking an increase of 11.43.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 21.54. This value is within the healthy range. It has increased from 13.26 (Mar 23) to 21.54, marking an increase of 8.28.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 185.70. It has increased from 73.51 (Mar 23) to 185.70, marking an increase of 112.19.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.11. This value is within the healthy range. It has increased from 0.45 (Mar 23) to 1.11, marking an increase of 0.66.
  • For EV / EBITDA (X), as of Mar 24, the value is 8.21. This value is within the healthy range. It has increased from 3.79 (Mar 23) to 8.21, marking an increase of 4.42.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.25. This value is within the healthy range. It has increased from 0.55 (Mar 23) to 1.25, marking an increase of 0.70.
  • For Retention Ratios (%), as of Mar 24, the value is 75.12. This value exceeds the healthy maximum of 70. It has increased from 73.51 (Mar 23) to 75.12, marking an increase of 1.61.
  • For Price / BV (X), as of Mar 24, the value is 2.60. This value is within the healthy range. It has increased from 1.22 (Mar 23) to 2.60, marking an increase of 1.38.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.25. This value is within the healthy range. It has increased from 0.55 (Mar 23) to 1.25, marking an increase of 0.70.
  • For EarningsYield, as of Mar 24, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.08 (Mar 23) to 0.05, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Denis Chem Lab Ltd as of March 12, 2025 is: ₹101.60

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 12, 2025, Denis Chem Lab Ltd is Overvalued by 2.31% compared to the current share price 104.00

Intrinsic Value of Denis Chem Lab Ltd as of March 12, 2025 is: 137.05

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 12, 2025, Denis Chem Lab Ltd is Undervalued by 31.78% compared to the current share price 104.00

Last 5 Year EPS CAGR: 34.89%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The company has higher reserves (35.69 cr) compared to borrowings (19.85 cr), indicating strong financial stability.
  2. The company has shown consistent growth in sales (116.69 cr) and profit (5.38 cr) over the years.
  1. The stock has a low average ROCE of 12.75%, which may not be favorable.
  2. The stock has a high average Working Capital Days of 54.17, which may not be favorable.
  3. The stock has a high average Cash Conversion Cycle of 42.42, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Denis Chem Lab Ltd:
    1. Net Profit Margin: 6.64%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 19.08% (Industry Average ROCE: 20.61%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 13.88% (Industry Average ROE: 61.74%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 21.54
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 2.18
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 14.3 (Industry average Stock P/E: 131.82)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.01
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Denis Chem Lab Ltd. is a Public Limited Listed company incorporated on 15/07/1980 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ1980PLC003843 and registration number is 003843. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 167.82 Cr. and Equity Capital is Rs. 13.88 Cr. for the Year ended 31/03/2024.
INDUSTRYADDRESSCONTACT
Medical Equipment & AccessoriesBlock No. 457, Village : Chhatral, Gandhi Nagar Dist. Gujarat 382729denischem401@gmail.com
http://www.denischemlab.com
Management
NamePosition Held
Mr. Dinesh B PatelChairman
Dr. Himanshu C PatelManaging Director
Dr. Gaurang K DalalIndependent Director
Dr. Gauri S TrivediIndependent Director
Mr. Hemendrakumar C ShahIndependent Director
Ms. Anar H PatelDirector

FAQ

What is the latest intrinsic value of Denis Chem Lab Ltd?

The latest intrinsic value of Denis Chem Lab Ltd as on 12 March 2025 is ₹101.60, which is 2.31% lower than the current market price of 104.00, indicating the stock is overvalued by 2.31%. The intrinsic value of Denis Chem Lab Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹144 Cr. and recorded a high/low of ₹233/101 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹69 Cr and total liabilities of ₹118 Cr.

What is the Market Cap of Denis Chem Lab Ltd?

The Market Cap of Denis Chem Lab Ltd is 144 Cr..

What is the current Stock Price of Denis Chem Lab Ltd as on 12 March 2025?

The current stock price of Denis Chem Lab Ltd as on 12 March 2025 is ₹104.

What is the High / Low of Denis Chem Lab Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Denis Chem Lab Ltd stocks is ₹233/101.

What is the Stock P/E of Denis Chem Lab Ltd?

The Stock P/E of Denis Chem Lab Ltd is 14.3.

What is the Book Value of Denis Chem Lab Ltd?

The Book Value of Denis Chem Lab Ltd is 59.4.

What is the Dividend Yield of Denis Chem Lab Ltd?

The Dividend Yield of Denis Chem Lab Ltd is 2.41 %.

What is the ROCE of Denis Chem Lab Ltd?

The ROCE of Denis Chem Lab Ltd is 20.1 %.

What is the ROE of Denis Chem Lab Ltd?

The ROE of Denis Chem Lab Ltd is 14.6 %.

What is the Face Value of Denis Chem Lab Ltd?

The Face Value of Denis Chem Lab Ltd is 10.0.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Denis Chem Lab Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE